Eraimplant - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 100,976 | 47,065 | 38,414 | 36,488 | 52,262 | 51,991 | 42,622 | 44,420 |
| Profit before tax | 3,181 | 1,423 | - | - | - | - | - | - |
| Net profit | 3,181 | 1,423 | 7,703 | -1,765 | 2,567 | -3,715 | -10,438 | -4,994 |
| Equity | 37,748 | 39,011 | 46,714 | 44,949 | 47,516 | 43,801 | 33,364 | 28,370 |
| Liabilities | 7,422 | 6,125 | 8,455 | 4,623 | 3,422 | 3,530 | 6,166 | 4,963 |
| Non-current assets | 6,186 | 5,080 | 3,573 | 822 | 586 | 351 | 2,376 | 1,632 |
| Current assets | 38,984 | 40,056 | 51,596 | 48,750 | 50,352 | 46,512 | 37,022 | 31,701 |
| Total assets | 45,170 | 45,136 | 55,169 | 49,572 | 50,938 | 46,863 | 39,398 | 33,333 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,560 | 4,059 | 3,444 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +39.7% | -53.4% | -18.4% | -5.0% | +43.2% | -0.5% | -18.0% | +4.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.0% | 3.2% | 14.0% | -3.6% | 5.0% | -7.9% | -26.5% | -15.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 8.4% | 3.6% | 16.5% | -3.9% | 5.4% | -8.5% | -31.3% | -17.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.2% | 3.0% | 20.1% | -4.8% | 4.9% | -7.1% | -24.5% | -11.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.2% | 3.0% | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 15,338 | 11,296 | 10,975 | 12,163 | 13,937 | 13,274 | 11,624 | 11,588 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Eraimplant - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-03-29 | 2026-04-13 | 0.14 |
| 2026-03-17 | 2026-03-27 | 0.14 |
| 2026-02-18 | 2026-03-04 | 0.14 |
| 2026-01-21 | 2026-02-11 | 0.14 |
| 2025-10-16 | 2025-10-26 | 45.94 |
| 2022-07-25 | 2022-08-02 | 0.37 |
| 2021-11-16 | 2021-12-14 | 0.04 |
| 2021-11-09 | 2021-11-14 | 0.04 |
| 2021-09-16 | 2021-09-21 | 20.32 |
Eraimplant - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Eraimplant, UAB (code 302660499) is a Private Limited Liability Company engaged in dental practice care activities. In 2025, the company generated revenue of €44.4K, up 4.2% year on year, after €42.6K in 2024 and €52.0K in 2023, showing a decline from the 2023 level followed by a modest recovery. Net profit remained negative in all three years: -€3.7K in 2023, -€10.4K in 2024, and -€5.0K in 2025. The 2025 profit margin was -11.2%, an improvement from -24.5% in 2024 but still below break-even. The balance sheet remained relatively small, with total assets of €33.3K, equity of €28.4K and liabilities of €5.0K at the end of 2025. Equity accounted for 85.1% of assets, and debt to equity stood at 0.17. Asset turnover was 1.33x. Return on equity was -17.6% and return on assets -15.0% in 2025. Revenue per employee was €14.8K, while profit per employee was -€1.7K.